Breakthrough Campus

ALD Breakthrough_9_5_21_Exteriors_5
ALD Breakthrough-230131-08304
ALD Breakthrough_Interior_0007
ALD Breakthrough-230131-08352
ALD Breakthrough_Interior_0061
ALD Breakthrough-Stock-210810-06169
ALD Breakthrough_Interior_Labs_
ALD Breakthrough-230131-07799
ALD Breakthrough Purification
ALD Breakthrough_Interior_Labs__12
ALD Breakthrough-230131-08448
ALD Breakthrough-Stock-210810-05731
ALD Breakthrough-230131-08056
ALD Breakthrough-210505-01592 copy
ALD Breakthrough-RNA-Lab-12_31_21_14
ALD Breakthrough_9_5_21_Exteriors_21

Breakthrough Campus - Fargo, North Dakota

cGMP and GMP-Source® Production of DNA, RNA and Protein
265,000 square feet of new, purpose-built construction

Aldevron’s Breakthrough Campus serves as HQ and as one of the world’s largest cGMP plasmid DNA manufacturing facilities. Breakthrough has been purpose built with the latest innovations and state-of-the-art equipment to produce DNA, mRNA drug substance, mRNA drug product, and protein. We serve thousands of clients, and each project is supported by an expert team delivering unmatched quality of product and experience – all backed by our strategically focused operations pathway ensuring efficiency along with scalability, to deliver the critical raw materials you need to accelerate your path to the clinic.


  • Aldevron headquarters
  • Manufacturing
  • Quality and regulatory
  • Ultra-low temperature freezer storage and distribution
  • Administration


  • cGMP and GMP-Source™ manufacturing of plasmid and Nanoplasmid DNA
    (supercoiled and linear)
  • cGMP manufacturing of mRNA drug substance and drug product with LNP encapsulation through sterile Fill & Finish
  • cGMP manufacturing of protein

Fast Facts (as of the end of 2022)

  • More than 5,000 lots of GMP-Source® & cGMP DNA produced
    • Supporting more than 1,000 advanced therapeutic companies worldwide
    • Part of nearly 1,100 global clinical trials
  • More than 100 mRNA drug substance batches in cGMP programs

Key Factor

  • This manufacturing facility was visited by the Center for Biologics Evaluation & Research (CBER) in November 2021. CBER conducted a Pre-License Inspection (PLI) and a general GMP audit of Aldevron, LLC. No Form FDA 483 was issued, and the inspection was classified as no action indicated (NAI)
  • FDA Establishment Identifier 3015047170

cGMP Manufacturing

  • 32 production suites that are state-of-the-art modular cleanrooms
    • Advanced independent air handling systems for cell banking, inoculation, and fill/finish
    • Designated client-specific and newly established mRNA production and fill/finish suites with capabilities to handle flammable liquids and BSL-2 classification
    • Multiple 30L and 300L single use microbial fermenters
    • 100% single-use consumables utilized for maximum efficiency
    • Multi-product capability

GMP-Source® Manufacturing

  • 13 production suites
    • ISO7 classified dispensing suite
    • pDNA focused – supercoiled and linear
    • Batch and Fed-batch fermentation at 30L and 300L scale
    • Stand-alone cell bank qualification/yield test lab

Advance Campus

Fargo, ND

R&D, process development, manufacturing for early-stage research

Innovate Campus

Madison, WI

R&D, process development, manufacturing for early stage research